- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medcross taps into Asian market
Imaging services provider Medcrossis joining forces with Magnecel Services (MSI) to access the potentiallylucrative Asia-Pacific market. The two companies have formed ajoint venture firm, Medpacific, to sell and service Elscint medicalimaging equipment
Imaging services provider Medcrossis joining forces with Magnecel Services (MSI) to access the potentiallylucrative Asia-Pacific market. The two companies have formed ajoint venture firm, Medpacific, to sell and service Elscint medicalimaging equipment and linear accelerators.
The move is a logical step for the companies, both of whichare based in Florida. Medcross recently signed a joint ventureagreement with the Chinese Health Ministry to import CT scannersinto China, while third-party service provider Magnecel is theexclusive Florida sales and service organization for Elscint medicalimaging products.
Medcross is the majority shareholder in the venture.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
